Residual Renal Function in Peritoneal Dialysis Patients

Abstract

Background: Peritoneal dialysis is used regularlly in treatment of ESRDs. Residual renal function (RRF) in these patients helps the adequacy of PD therapy very much. Objectives: 1. Study RRF of PD patients at Department of Nephro – Rheumatology, Hue Central Hospital. 2. Search the correlation between RRF and Kt/V. Patients and methods: 35 PD patients at Department of Nephro – Rheumatology, Hue Central Hospital. Measure RRF and Kt/V by formulars that depend on blood, urine and PD fluid samples. Results: Mean RRF of PD patients is 4.36 ± 13.8 ml/minute. There is a close correlation between RRF and Kt/V (r=0.79, p<0.01). Conclusion: RRF in PD patients correlates with Kt/V.

Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials

“…The previous SR and CPG search yielded two SRs [25,26] which contained four [10,11,15,27] and six [10,[15][16][17][18]20] RCTs in each, with two [10,15] duplicated. We thus identified eight articles from this step.…”

“…Two studies compared the effects of ACEIs and ARBs with a cross-over RCT [16], and a parallel RCT [20]. The remaining five studies assessed the effects of ARB [11,15,[17][18][19], where one study conducted two intervention groups using different ARBs [19]. Table 2 summarizes the details of our assessment of the risk of bias among the included studies.…”

“…Four studies used computer-generated lists for randomization [10,15,17,18]. Two of these had not detailed the randomization method [17,18], but the authors of a previous SR confirmed that these studies also used the computergenerated methods [26]. One study provided no information on allocation concealment [18].…”

“…Two of these had not detailed the randomization method [17,18], but the authors of a previous SR confirmed that these studies also used the computergenerated methods [26]. One study provided no information on allocation concealment [18]. Three studies had incomplete outcome data [16][17][18].…”

“…In view of these facts, the clinical question arose as to whether RASIs preserve the RRF of PD patients. Several clinical studies were performed to estimate the effect of RASIs on RRF of PD patients [10][11][12][13][14][15][16][17][18][19][20][21][22], including both randomized controlled trials (RCTs) and non-RCTs, with conflicting results.…”